Walmart Investors Balk At Stay Request In Del. Opioid Suit
Three institutional investors that have accused Walmart officers and directors of failing to maintain proper control over the retailer's distribution of prescription opioids are pushing back on a motion seeking to...To view the full article, register now.
Already a subscriber? Click here to view full article